CRVS
#2497
Corvus Pharmaceuticals, Inc. - Common Stock
10.0 5 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-4.47%
Variazione Mensile
-22.21%
Variazione di 6 mesi
-33.93%
Variazione Annuale
+45.65%
Chiusura Precedente
10.5 2
Open
10.4 3
Minimo
10.0 2
Massimo
10.5 0
Financials
2021
Quarterly report, Q2 FY2021
Corvus Pharmaceuticals, Inc. quarterly report, Q2 FY2021
10-Q
Current report, 15 Jun 2021
Corvus Pharmaceuticals, Inc. current report, 15 June 2021
8-K
Current report, 29 Apr 2021
Corvus Pharmaceuticals, Inc. current report, 29 April 2021
8-K
Quarterly report, Q1 FY2021
Corvus Pharmaceuticals, Inc. quarterly report, Q1 FY2021
10-Q
Current report, 25 Mar 2021
Corvus Pharmaceuticals, Inc. current report, 25 March 2021
8-K
Current report, 18 Mar 2021
Corvus Pharmaceuticals, Inc. current report, 18 March 2021
8-K
Current report, 12 Feb 2021
Corvus Pharmaceuticals, Inc. current report, 12 February 2021
8-K
Current report, 11 Feb 2021
Corvus Pharmaceuticals, Inc. current report, 11 February 2021
8-K
Current report, 04 Feb 2021
Corvus Pharmaceuticals, Inc. current report, 04 February 2021
8-K
2020
Annual report, FY2020
Corvus Pharmaceuticals, Inc. annual report, FY2020
10-K